J&J
Johnson & Johnson Breaks Into Prostate Cancer Market with Akeega
SG Tylor
After the FDA’s green light for AstraZeneca/Merck and Pfizer’s PARP inhibitors, Johnson & Johnson (J&J) has now secured its own ...
Another Stelara patent settlement was reached by J&J, this time with Alvotech and Teva
SG Tylor
Source – Johnson & Johnson By early 2025, a new settlement may allow for the entry of a second biosimilar ...
Johnson & Johnson (J&J) Moves Closer to FDA Approval for CAR-T Therapy
SG Tylor
The company has filed for approval to use Carvykti earlier in the treatment pathway, including for patients experiencing their first ...
